Fresenius Kabi USA

Building an extensive portfolio of smart labeled medications.

+RFID™ is a new portfolio of smart labeled medications manufactured by Fresenius Kabi. Launched in 2020, the +RFID portfolio supports a safer and more efficient inventory process for hospital pharmacies.

Multiple created the +RFID brand and a system of materials to launch the new portfolio and its first product. Backed by research and insights, Multiple developed key messaging to communicate why +RFID is a worthwhile investment. Through journal ads and educational materials, customers are driven to a custom microsite for more information about +RFID and the available portfolio.

Visit site

The +RFID identity was developed to work across a broad range of sizes and applications, from digital screens to small printed labels.

Multiple developed a responsive microsite with animated illustrations to further explain how the +RFID Smart Labels are designed.

Multiple Fresenius Kabi PlusRFID Mobile Screens

Multiple Fresenius Kabi PlusRFID Available Soon Advertisement

A launch strategy was created to raise awareness for the new +RFID portfolio through a system of brand materials that can be updated and reused as additional products become available.